References
- Weinstein G. D., Gottlieb A. National Psoriasis Foundation: Therapy of moderate‐to‐severe psoriasis. 2nd ed. National Psoriasis Foundation. 1993
- Schon M. P., Boehncke W. H. Psoriasis. N Engl J Med 2005; 352: 1899–912
- Finlay A. Y., Khan G. K. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–16
- Ellis C. N., Fradin M. S., Messana J. M., et al. Cyclosporine for plaque‐type psoriasis. Results of a multidose, double‐blind trial [see comments]. N Engl J Med 1991; 324: 277–84
- Greaves M. W., Weinstein G. D. Treatment of psoriasis. N Engl J Med 1995; 332: 581–8
- Camisa C. Psoriasis. Blackwell Scientific Publications, Oxford 1994
- Gottlieb A. B. Alefacept is well tolerated in patients with chronic plaque psoriasis. J Cutan Med Surg 2004; 8((suppl 2))14–19
- Hodak E., David M. Alefacept: a review of the literature and practical guidelines for management. Dermatol Ther 2004; 17: 383–92
- Krueger G. G., Callis K. P. Development and use of alefacept to treat psoriasis. J Am Acad Dermatol 2003; 49((2 suppl))S87–S97